These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1881009)

  • 1. [The significance of bacillus Calmette-Guerin in the therapy of carcinoma in situ of the bladder].
    Kurozumi T; Koikawa Y; Yagi H; Omoto T; Iwata Y
    Nihon Hinyokika Gakkai Zasshi; 1991 Jun; 82(6):900-6. PubMed ID: 1881009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of early failures after intravesical instillation therapy with bacille Calmette-Guérin for carcinoma in situ of the bladder.
    Merz VW; Marth D; Kraft R; Ackermann DK; Zingg EJ; Studer UE
    Br J Urol; 1995 Feb; 75(2):180-4. PubMed ID: 7850322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder. Gifu BCG Instillation Therapy Research Group].
    Nishino Y; Yasuda M; Yokoi S; Ehara H; Yamamoto N; Takahashi Y; Ishihara S; Deguchi T; Kawada Y; Takeda A; Sakai S; Takeuchi T; Taniguchi M; Minoshima K; Hamamoto Y; Kanimoto Y; Nakano M; Fujihiro S; Nezasa S; Matsuda T; Nagatani Y; Maeda S; Tamaki M; Saito A; Komeda H
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1869-73. PubMed ID: 10560414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized comparison of intravesical with percutaneous bacillus Calmette-Guerin versus intravesical bacillus Calmette-Guerin in superficial bladder cancer.
    Lamm DL; DeHaven JI; Shriver J; Sarosdy MF
    J Urol; 1991 Apr; 145(4):738-40. PubMed ID: 2005691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus Calmette-Guérin treatment of existing papillary bladder cancer and carcinoma in situ of the bladder. Four-year results. The Bladder Cancer BCG Study Group.
    Akaza H; Hinotsu S; Aso Y; Kakizoe T; Koiso K
    Cancer; 1995 Jan; 75(2):552-9. PubMed ID: 7812924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of keyhole limpet hemocyanin (KLH) and bacillus Calmette-Guérin (BCG) instillation on carcinoma in situ of the urinary bladder.
    Jurincic-Winkler C; Metz KA; Beuth J; Sippel J; Klippel KF
    Anticancer Res; 1995; 15(6B):2771-6. PubMed ID: 8669862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of intravesical bacillus Calmette-Guérin therapy with maintenance for urinary bladder carcinoma in situ: About 47 cases.
    Sallami S; Khouni H; Ben Atta M; Abou El Makarim S; Zouari MB; Ben Rhouma S
    Tunis Med; 2016 Dec; 94(12):844. PubMed ID: 28994883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of tumor-associated macrophages count in human non-muscle-invasive bladder cancer treated by BCG immunotherapy.
    Ajili F; Kourda N; Darouiche A; Chebil M; Boubaker S
    Ultrastruct Pathol; 2013 Feb; 37(1):56-61. PubMed ID: 23383616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical observation of 8 cases of carcinoma in situ of the urinary bladder].
    Murase T; Ito H; Ohishi M; Takashi M
    Hinyokika Kiyo; 1989 Apr; 35(4):583-5. PubMed ID: 2735263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term followup of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: analysis of possible predictors of response free of tumor.
    Coplen DE; Marcus MD; Myers JA; Ratliff TL; Catalona WJ
    J Urol; 1990 Sep; 144(3):652-7. PubMed ID: 2388321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical instillation of bacille Calmette-Guérin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter.
    Irie A; Iwamura M; Kadowaki K; Ohkawa A; Uchida T; Baba S
    Urology; 2002 Jan; 59(1):53-7. PubMed ID: 11796281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of 6 weekly intravesical bacillus Calmette-Guerin instillations on the treatment of superficial bladder tumors.
    Kavoussi LR; Torrence RJ; Gillen DP; Hudson MA; Haaff EO; Dresner SM; Ratliff TL; Catalona WJ
    J Urol; 1988 May; 139(5):935-40. PubMed ID: 3361667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased infiltration of tumor associated macrophages is associated with poor prognosis of bladder carcinoma in situ after intravesical bacillus Calmette-Guerin instillation.
    Takayama H; Nishimura K; Tsujimura A; Nakai Y; Nakayama M; Aozasa K; Okuyama A; Nonomura N
    J Urol; 2009 Apr; 181(4):1894-900. PubMed ID: 19237175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible factors affecting response to intravesical bacillus Calmette-Guérin (Tokyo 172 strain) therapy for carcinoma in situ of the bladder: a multivariate analysis.
    Takashi M; Katsuno S; Yuba H; Ohshima S; Wakai K; Ohno Y
    Int Urol Nephrol; 1998; 30(6):713-22. PubMed ID: 10195866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
    Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravesical immunotherapy of in situ carcinoma of the urinary bladder using Bacillus Calmette-Guerin (BCG)].
    Jakse G
    Wien Klin Wochenschr; 1987 Feb; 99(4):114-8. PubMed ID: 3577186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravesical bacillus Calmette-Guerin instillation therapy of recurrent superficial bladder carcinomas resistant to intravesical anti-cancer chemotherapy].
    Takeuchi S; Kihara K; Higashi Y; Fukui I; Oshima H
    Hinyokika Kiyo; 1989 Apr; 35(4):577-81. PubMed ID: 2735262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squamous cell carcinoma of bladder after successful intravesical therapy with Bacillus Calmette-Guérin.
    Brenner DW; Yore LM; Schellhammer PF
    Urology; 1989 Aug; 34(2):93-5. PubMed ID: 2763404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of carcinoma in situ of the urinary bladder].
    Harada Y; Seguchi T; Nonomura N; Kojima Y; Miki T; Okuyama A
    Nihon Hinyokika Gakkai Zasshi; 1998 Aug; 89(8):693-7. PubMed ID: 9780653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG treatment of existing Ta, T1 tumours or carcinoma in situ of the bladder.
    Akaza H
    Eur Urol; 1995; 27 Suppl 1():9-12. PubMed ID: 7750530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.